The note states Symbiotec Pharmalab received a US FDA Establishment Inspection Report classifying its Pithampur facility under Voluntary Action Indicated (VAI) status.
Read this note →Symbiotec Pharmalab Limited
NSE SYMBIOTEC BSE 544889 INE899I01028
0 filings · 0 analysed
1,554.70
+41.63%
over 1 year
-
The note states Symbiotec Pharmalab received a US FDA Establishment Inspection Report classifying its Pithampur facility under Voluntary Action Indicated (VAI) status.
-
The report says Symbiotec Pharmalab, at Rs 1,757 crore, was the largest IPO among the week's listed companies and has a 20+ year business vintage.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
What the desks said
The report says Symbiotec Pharmalab, at Rs 1,757 crore, was the largest IPO among the week's listed companies and has a 20+ year business vintage.
Read this note →The note says it launched the week's largest IPO at Rs 1,757 crore in the pharmaceutical sector.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief